Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Commencement of phase II trials of LiquiVent for adult ARDS

Dec. 31, 1997

IL-5 receptor ligands reported by Glaxo Wellcome

Dec. 31, 1997

New treatment approach for nasal congestion

Dec. 30, 1997

TOBI approved by FDA for management of CF patients

Dec. 29, 1997

New antiallergic agents from Dainippon Ink & Chemicals

Dec. 29, 1997

Teijin starts clinical trials of in-licensed antiasthmatic drug

Dec. 24, 1997

Boehringer Ingelheim to develop and market Procysteine in Japan

Dec. 24, 1997

Jouveinal patents PDE IV inhibitors

Dec. 24, 1997

HNE inhibitors prepared at Glaxo Wellcome

Dec. 24, 1997

Neurokinin antagonists in the pipeline at Schering-Plough

Dec. 23, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...